MedTrace Logo

A Phase I Feasibility Study of an Intracortical Visual Prosthesis (ICVP) for People With Blindness

NCT04634383 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2022-01-11

No results posted yet for this study

Summary

The purpose of this study is to determine the feasibility of producing artificial vision in persons with blindness. Study participants will have wireless electrical stimulators implanted into the cortical vision processing areas of their brains. The ability of the participants to perceive artificial vision in response to electrical stimulation will be assessed.

Conditions

  • Ocular Injury
  • Optic Nerve Diseases
  • Photoreceptor Degeneration
  • Blindness,Acquired

Interventions

DEVICE

WFMA - wireless floating microelectrode array

Wirelessly transmitted patterns of electrical stimulation will be delivered to the visual cortex of study participants to generate visual percepts.

Sponsors & Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • Rush University Medical Center

    collaborator OTHER

  • The Chicago Lighthouse

    collaborator OTHER

  • The University of Texas at Dallas

    collaborator OTHER

  • University of Chicago

    collaborator OTHER

  • Johns Hopkins University

    collaborator OTHER

  • Illinois Institute of Technology

    lead OTHER

Principal Investigators

  • Philip R Troyk, PhD · Illinois Institute of Technology

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-20
Primary Completion
2023-08-31
Completion
2023-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04634383 on ClinicalTrials.gov